Canadian Real-World Outcomes of Omnipod Initiation in People With T1D

CompletedOBSERVATIONAL
Enrollment

286

Participants

Timeline

Start Date

January 20, 2020

Primary Completion Date

February 9, 2020

Study Completion Date

February 9, 2020

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

Omnipod

Switch from MDI therapy to an Omnipod as part of usual clinical practice. An Omnipod is a patch pump that consists of a handheld controller and a disposable pod that delivers insulin.

OTHER

MDI

Continued use of MDI therapy (traditional basal/bolus insulin regimen).

Trial Locations (1)

Unknown

LMC Healthcare, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Insulet Corporation

INDUSTRY

lead

LMC Diabetes & Endocrinology Ltd.

OTHER

NCT04226378 - Canadian Real-World Outcomes of Omnipod Initiation in People With T1D | Biotech Hunter | Biotech Hunter